EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System

Dan Haberman, Kalyan R Chitturi, Lior Lupu, Jason P Wermers, Ron Waksman iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Dan Haberman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Sympathectomy, Hypertension, Renal Artery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension continues to be a prominent, avoidable factor contributing to major vascular issues on a global scale. Even with lifestyle adjustments and more aggressive medical treatments, maintaining optimal blood pressure levels remains challenging. This challenge has driven the emergence of device‐oriented approaches to address hypertension. To assess the safety and efficacy of the Recor Paradise Ultrasound Renal Denervation System, the Circulatory System Devices Panel was convened by the US Food and Drug Administration (FDA). This manuscript provides a condensed overview of the information put forth by the sponsor and the FDA, along with an account of the considerations and conversations that took place during the meeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationSympathectomyHypertensionRenal ArteryBlood PressureDevice ApprovalHumansUnited StatesTreatment OutcomeKidneyAdvisory CommitteesEquipment DesignRisk Factors

Stichwörter der Autor:innen

clinical trialscomparative effectiveness/patient‐centered outcomes researchhypertensioninterventional devices/innovationsympathetic denervation

Autor:innen und Institutionen

  • Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

ORCID-Profile: Ron Waksman

Zitieren

APA

Haberman, D., Chitturi, K. R., Lupu, L., Wermers, J. P., & Waksman, R. (2024). Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31065

Vancouver

Haberman D, Chitturi KR, Lupu L, Wermers JP, Waksman R. Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31065

BibTeX
@article{Haberman2024,
  author = {Haberman, Dan and Chitturi, Kalyan R and Lupu, Lior and Wermers, Jason P and Waksman, Ron},
  title = {Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31065}
}
Kostenlos starten →